SEMGLEE

This brand name is authorized in Australia, Ecuador, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, New Zealand, Poland, Romania, United Kingdom, United States

Active ingredients

The drug SEMGLEE contains one active pharmaceutical ingredient (API):

1 Insulin glargine UNII 2ZM8CX04RZ - INSULIN GLARGINE

Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. After injection, the acidic solution is neutralised leading to formation of a precipitate from which small amounts of insulin glargine are continuously released. Read about Insulin glargine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SEMGLEE Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10AE04	Insulin glargine	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
Discover more medicines within A10AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11815W
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 179-MBE-0221, 237-MBE-1022
Country: EE	Ravimiamet	Identifier(s): 1768091, 1768103, 1768114, 1793257
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181270003
Country: FR	Base de données publique des médicaments	Identifier(s): 60408661
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 360830, 391978
Country: IT	Agenzia del Farmaco	Identifier(s): 046350017, 046350029, 046350031, 046350043, 046350056
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1085343, 1085344, 1085345, 1088580, 1088581
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20004
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100405550
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64292001, W64292002, W64292003
Country: US	FDA, National Drug Code	Identifier(s): 49502-195, 49502-196